JPMorgan analyst Lisa Gill downgraded Oak Street Health to Neutral from Overweight with a price target of $39, up from $35, citing the pending acquisition by CVS Health for $39 per share.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH:
- Oak Street Health downgraded to Market Perform from Outperform at Bernstein
- Oak Street Health downgraded to Market Perform from Outperform at Raymond James
- CVS Health price target raised to $143 from $130 at Jefferies
- Oak Street Health downgraded to Hold from Buy at Jefferies
- Oak Street Health downgraded to Market Perform from Outperform at William Blair